Showing posts with label hand-foot reactions. Show all posts
Showing posts with label hand-foot reactions. Show all posts
Saturday, January 07, 2012
open access: Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
Background: This study describes a repeated measures prediction index to identify patients at high risk of ≥ grade 2 hand-foot skin reaction (HFSR) before each week of sorafenib therapy.
Results: Pretreatment white blood cell count, female gender, good performance status, presence of lung and liver metastases and number of affected organs were predictors for ≥ grade 2 HFSR.
add your opinions
adverse events
,
hand-foot reactions
,
Sorafenib
Subscribe to:
Posts
(
Atom
)